- You can view the full Stereotaxis Ratings Report.
- Use our health services section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Shares of Stereotaxis (STXS) are up today after announcing that it has received 510(k) clearance by the FDA for its Vdrive(R) with V-CAS(TM) Catheter Advancement System in the U.S.
Stocks with insider trader activity include CODE, COV and STXS